Recent News

• 12.03.2025 - Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
• 11.17.2025 - UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
• 11.14.2025 - Lifeward Ltd. Reports Third Quarter 2025 Financial Results
• 11.10.2025 - Lifeward to Report Third Quarter Financial Results on November 14, 2025
• 09.09.2025 - First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
• 09.09.2025 - First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
• 09.09.2025 - First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
• 09.08.2025 - Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
• 09.08.2025 - Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
• 09.08.2025 - Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

Recent Filings

• 12.01.2025 - DEF 14A Other definitive proxy statements
• 11.21.2025 - PRE 14A Other preliminary proxy statements
• 11.14.2025 - EX-99.1 EX-99.1
• 11.14.2025 - 8-K Current report
• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.16.2025 - 8-K Current report
• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.25.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 08.25.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments